Grifols approves IPO of its US biopharma business
March 24 (Reuters) - Healthcare company Grifols GRLS.MC said on Tuesday it has approved a U.S. initial public offering of its U.S. biopharma business. (Reporting by Fabiola Arámburo in Mexico City; Editing by Alan Barona) ((Fabiola.Solano@thomsonreuters.com))
Recent news on Grifols
See all newsSpanish stocks - Factors to watch on Nov 3
Brief: Grifols Approves Interim Dividend Of €0.15/Shr Payable On Dec 4
Brief: Grifols Q3 Group Profit €162 Mln
Refile: Grifols says Canada plasma license suspension has no impact on ongoing operations
Brief: Health Canada Suspends Licence Of Grifols Site In Winnipeg - Globe And Mail